Nitric oxide synthase inhibition augments acute allergic reactions in the pig airways in vivo.
The aim of this study was to examine the effects of nitric oxide synthase inhibition on antigen- and histamine-induced acute airway reactions, in order to clarify the possible modulating role of NO. Twelve specific-pathogen-free pigs (sensitized with Ascaris suum antigen) were challenged with an antigen aerosol during mechanical ventilation and anaesthesia. Six pigs were pretreated with N(G)-nitro-L-arginine (L-NA, 10 mg x kg(-1)), a NO synthase inhibitor, 30 min before challenge. In separate experiments, seven sensitized pigs received histamine (5 mg) aerosols before and after L-NA treatment. It was found that pretreatment with L-NA resulted in an enhanced airways resistance response to antigen (areas under the curve 0-90 min were (mean+/-SEM) 1,119+/-160 versus 555+/-56 (cmH2O x L(-1) x s(-1) x min for controls, p<0.05 (Mann-Whitney U-test), whereas this response to histamine was not affected by L-NA. Moreover, L-NA pretreatment significantly enhanced total protein (1.85+/-0.43 versus 0.31+/-0.06 g x L(-1), p<0.01) and histamine levels (42.8+/-16.0 versus 2.6+/-0.8 nM, p<0.05) in bronchoalveolar lavage fluid 45 min after antigen challenge. In conclusion, this study showed that N(G)-nitro-L-arginine enhanced reactions occurring during the acute allergic reaction in pigs in vivo. This indicates a protective role of nitric oxide, which might occur through downregulation of histamine release from mast cells rather than a direct bronchodilating effect of nitric oxide.
Middelveld
R J
RJ
Dept of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Zetterquist
W C
WC
Bergman
D
D
Alving
K
K
D000208:Acute Disease; D000403:Airway Resistance; D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology; D017165:Ascaris suum / Q000276:immunology; D001980:Bronchi / Q000503:physiopathology; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D002319:Cardiovascular System / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005740:Gases / Q000097:blood; D006632:Histamine / Q000276:immunology; D006863:Hydrogen-Ion Concentration; D006967:Hypersensitivity / Q000276:immunology* / Q000503:physiopathology; D018836:Inflammation Mediators / Q000032:analysis / Q000652:urine; D008170:Lung Compliance; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D019335:Nitroarginine / Q000494:pharmacology*; D013552:Swine
D000947:Antigens, Helminth; D004791:Enzyme Inhibitors; D005740:Gases; D018836:Inflammation Mediators; D019335:Nitroarginine; D006632:Histamine; D019001:Nitric Oxide Synthase